Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Milciclib in Malignant Thymoma
NCT01301391Phase 2Terminated
- Sponsor
- Tiziana Life Sciences
- Start
- Feb 2011
- Primary completion
- May 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of milciclib in thymoma, thymic carcinoma (TC), sponsored by Tiziana Life Sciences. Started Feb 2011; status: terminated.
02
Drugs
milciclib
03
Conditions
thymomathymic carcinoma (TC)
Beyond the preview
Go deeper on NCT01301391.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01301391.